CDY7P

Across TCGA pan-cancer cohorts, CDY7P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated CDY7P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CDY7P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CDY7P expression acts as an unfavorable survival marker, although some lineages such as KIRC and PAAD show a favorable association.

KIRP, UCS, and COAD are the cancer types where CDY7P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.360	0.805	<.001	75	view →
UCS	OS	Tertile	II,III,IV	0.254	0.620	.044	36	view →
COAD	OS	Tertile	III,IV	0.140	0.780	.007	27	view →
PCPG	OS	Tertile	All	0.828	0.963	<.001	18	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	12	view →
KIRC	DFS	Tertile	IV	0.821	0.587	.039	12	view →
PAAD	DFS	Tertile	II,III,IV	1.000	0.247	.030	9	view →
HNSC	DFS	Tertile	II,III,IV	0.232	0.564	.016	9	view →
THYM	OS	Tertile	II,III,IV	0.704	0.982	.009	6	view →
LIHC	DFS	Tertile	II,III,IV	0.582	0.289	.030	6	view →
ESCA	OS	Tertile	All	0.580	0.730	.042	3	view →
SARC	OS	Tertile	All	0.358	0.623	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

CDY7P–KIRP (OS)

Open the KIRP breakdown →